You are here:
Link between basic research, clinical areas and key technologies
The BCRT was founded in 2006 as an alliance between the Charité – Universitätsmedizin Berlin, one of Europe's largest university clinics, and the Helmholtz Association, Germany's largest research institution. A team of over 250 employees (physicians, scientists, engineers, experts in translational medicine, PhD students and technical staff ) are conducting research at the BCRT's two sites: at the BCRT building on the Virchow Clinic Campus of the Charité, with its close links to the BCRT partner clinics, and at the Teltow Campus of the Helmholtz Centre Geesthacht within the Centre for Biomaterial Development.
The BCRT was established as an interdisciplinary translational center with the goal of understanding the body's inherent healing processes so that they can be used to develop and implement innovative therapies. The primary focus of the BCRT is on diseases of the immune system, the musculoskeletal system and the cardiovascular system for which currently only unsatisfactory treatment options are available. At the BCRT clinicians and researchers are working hand in hand on the medicine of the future: targeted, patient-centred medicine that depends on the early recognition of patients' individual healing potential.